Gilead snags Lilly exec Shaw for Kite CEO position
Back in May, new Gilead Sciences CEO Daniel O’Day said he’d be looking for a CEO for Gilead’s Kite unit. And he’s found his pick. Thursday, the Big Biotech said it would bring on Eli Lilly executive Christi Shaw to run the cell therapy company, which Gilead snagged in 2017 for $ 12 billion. She’ll… Read More »